These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12042267)

  • 1. Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men.
    Kinniburgh D; Zhu H; Cheng L; Kicman AT; Baird DT; Anderson RA
    Hum Reprod; 2002 Jun; 17(6):1490-501. PubMed ID: 12042267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.
    Brady BM; Walton M; Hollow N; Kicman AT; Baird DT; Anderson RA
    Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone.
    Anderson RA; Van Der Spuy ZM; Dada OA; Tregoning SK; Zinn PM; Adeniji OA; Fakoya TA; Smith KB; Baird DT
    Hum Reprod; 2002 Nov; 17(11):2869-77. PubMed ID: 12407041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men.
    Walton MJ; Kumar N; Baird DT; Ludlow H; Anderson RA
    J Androl; 2007; 28(5):679-88. PubMed ID: 17460095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.
    Kinniburgh D; Anderson RA; Baird DT
    J Androl; 2001; 22(1):88-95. PubMed ID: 11191092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men.
    Martin CW; Riley SC; Everington D; Groome NP; Riemersma RA; Baird DT; Anderson RA
    Hum Reprod; 2000 Jul; 15(7):1515-24. PubMed ID: 10875859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.
    Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception.
    Anderson RA; Kinniburgh D; Baird DT
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3640-9. PubMed ID: 12161488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.
    Anawalt BD; Herbst KL; Matsumoto AM; Mulders TM; Coelingh-Bennink HJ; Bremner WJ
    Fertil Steril; 2000 Oct; 74(4):707-14. PubMed ID: 11020511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and prospects in male hormonal contraception.
    Amory JK
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):255-60. PubMed ID: 18438174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel male contraceptive pill-patch combination: oral desogestrel and transdermal testosterone in the suppression of spermatogenesis in normal men.
    Hair WM; Kitteridge K; O'Connor DB; Wu FC
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5201-9. PubMed ID: 11701677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid hormones for contraception in men.
    Grimes DA; Lopez LM; Gallo MF; Halpern V; Nanda K; Schulz KF
    Cochrane Database Syst Rev; 2012 Mar; (3):CD004316. PubMed ID: 22419294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
    Guerin JF; Rollet J
    Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate.
    Anderson RA; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.